Literature DB >> 34378991

Nicotinamide N-methyltransferase upregulation via the mTORC1-ATF4 pathway activation contributes to palmitate-induced lipotoxicity in hepatocytes.

Alexandra Griffiths1, Jun Wang1,2, Qing Song1, Iredia D Iyamu3, Lifeng Liu4, Jooman Park4, Yuwei Jiang4, Rong Huang3, Zhenyuan Song1.   

Abstract

Defined as the dysfunction and/or cell death caused by toxic lipids accumulation in hepatocytes, hepatic lipotoxicity plays a pathological role in nonalcoholic fatty liver disease. The cellular and molecular mechanisms underlying lipotoxicity remain to be elucidated. In this study, using AML12 cells, a nontransformed murine hepatocyte cell line, exposed to palmitate (a 16-C saturated fatty acid) as an experimental model, we investigated the role and mechanisms of nicotinamide N-methyltransferase (NNMT), a methyltransferase catalyzing nicotinamide methylation and degradation, in hepatic lipotoxicity. We initially identified activating transcription factor 4 (ATF4) as a major transcription factor for hepatic NNMT expression. Here, we demonstrated that palmitate upregulates NNMT expression via activating ATF4 in a mechanistic target of rapamycin complex 1 (mTORC1)-dependent mechanism in that mTORC1 inhibition by both Torin1 and rapamycin attenuated ATF4 activation and NNMT upregulation. We further demonstrated that the mTORC1-dependent ATF4 activation is an integral signaling event of unfolded protein response (UPR) as both ATF4 activation and NNMT upregulation by tunicamycin, a well-documented endoplasmic reticulum (ER) stress inducer, are blunted when hepatocytes were pretreated with Torin1. Importantly, our data uncovered that NNMT upregulation contributes to palmitate-induced hepatotoxicity as NNMT inhibition, via either pharmacological (NNMT inhibitors) or genetic approach (siRNA transfection), provided protection against palmitate lipotoxicity. Our further mechanistic exploration identified protein kinase A (PKA) activation to contribute, at least, partially to the protective effect of NNMT inhibition against lipotoxicity. Collectively, our data demonstrated that NNMT upregulation by the mTORC1-ATF4 pathway activation contributes to the development of lipotoxicity in hepatocytes.

Entities:  

Keywords:  ATF4; NNMT; PKA; lipotoxicity; mTORC1; palmitate

Mesh:

Substances:

Year:  2021        PMID: 34378991      PMCID: PMC8461816          DOI: 10.1152/ajpcell.00195.2021

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   5.282


  33 in total

Review 1.  Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?

Authors:  Mohamed Asrih; François R Jornayvaz
Journal:  Mol Cell Endocrinol       Date:  2015-02-24       Impact factor: 4.102

2.  The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress.

Authors:  Morten Luhr; Maria Lyngaas Torgersen; Paula Szalai; Adnan Hashim; Andreas Brech; Judith Staerk; Nikolai Engedal
Journal:  J Biol Chem       Date:  2019-03-29       Impact factor: 5.157

3.  Nicotinamide ameliorates palmitate-induced ER stress in hepatocytes via cAMP/PKA/CREB pathway-dependent Sirt1 upregulation.

Authors:  Jiaxin Li; Xiaobing Dou; Songtao Li; Ximei Zhang; Yong Zeng; Zhenyuan Song
Journal:  Biochim Biophys Acta       Date:  2015-09-06

4.  mTORC1-IRE1α pathway activation contributes to palmitate-elicited triglyceride secretion and cell death in hepatocytes.

Authors:  Jun Wang; Yingli Chen; Qing Song; Alexandra Griffiths; Zhenyuan Song
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-21

Review 5.  NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.

Authors:  Amélio F Godoy-Matos; Wellington S Silva Júnior; Cynthia M Valerio
Journal:  Diabetol Metab Syndr       Date:  2020-07-14       Impact factor: 3.320

6.  Inhibition of mTOR reduces lipotoxic cell death in primary macrophages through an autophagy-independent mechanism.

Authors:  Li He; Kassandra J Weber; Abhinav Diwan; Joel D Schilling
Journal:  J Leukoc Biol       Date:  2016-06-16       Impact factor: 4.962

7.  Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.

Authors:  Daniel Kraus; Qin Yang; Dong Kong; Alexander S Banks; Lin Zhang; Joseph T Rodgers; Eija Pirinen; Thomas C Pulinilkunnil; Fengying Gong; Ya-chin Wang; Yana Cen; Anthony A Sauve; John M Asara; Odile D Peroni; Brett P Monia; Sanjay Bhanot; Leena Alhonen; Pere Puigserver; Barbara B Kahn
Journal:  Nature       Date:  2014-04-10       Impact factor: 49.962

8.  NNMT activation can contribute to the development of fatty liver disease by modulating the NAD + metabolism.

Authors:  Motoaki Komatsu; Takeshi Kanda; Hidenori Urai; Arata Kurokochi; Rina Kitahama; Shuhei Shigaki; Takashi Ono; Hideo Yukioka; Kazuhiro Hasegawa; Hirobumi Tokuyama; Hiroshi Kawabe; Shu Wakino; Hiroshi Itoh
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

9.  mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β1-induced collagen biosynthesis.

Authors:  Brintha Selvarajah; Ilan Azuelos; Manuela Platé; Delphine Guillotin; Ellen J Forty; Greg Contento; Hannah V Woodcock; Matthew Redding; Adam Taylor; Gino Brunori; Pascal F Durrenberger; Riccardo Ronzoni; Andy D Blanchard; Paul F Mercer; Dimitrios Anastasiou; Rachel C Chambers
Journal:  Sci Signal       Date:  2019-05-21       Impact factor: 8.192

10.  Twenty-five years of mTOR: Uncovering the link from nutrients to growth.

Authors:  David M Sabatini
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-25       Impact factor: 11.205

View more
  4 in total

1.  Exploring Unconventional SAM Analogues To Build Cell-Potent Bisubstrate Inhibitors for Nicotinamide N-Methyltransferase.

Authors:  Iredia D Iyamu; Jonah Z Vilseck; Ravi Yadav; Nicholas Noinaj; Rong Huang
Journal:  Angew Chem Int Ed Engl       Date:  2022-02-23       Impact factor: 15.336

2.  The Storage Conditions of High-Fat Diet Are the Key Factors for Diet-Induced Obesity and Liver Damage.

Authors:  Chuanyou Yi; Dandan Li; Xiao Guo; Jinhui Wang; Cenxi Liu; Guangxing Lu; Yan Sun; He Huang; Shangyu Hong; Jin Li
Journal:  Nutrients       Date:  2022-05-26       Impact factor: 6.706

3.  Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders.

Authors:  Sven Ruf; Sridharan Rajagopal; Sanjay Venkatachalapathi Kadnur; Mahanandeesha S Hallur; Shilpa Rani; Rajendra Kristam; Srinivasan Swaminathan; Bharat Ravindra Zope; Pavan Kumar Gondrala; Indu Swamy; V P Rama Kishore Putta; Saravanan Kandan; Gernot Zech; Herman Schreuder; Christine Rudolph; Ralf Elvert; Joerg Czech; Swarnakumari Birudukota; M Amir Siddiqui; Niranjan Naranapura Anand; Vishal Subhash Mane; Sreekanth Dittakavi; Juluri Suresh; Ramachandraiah Gosu; Mullangi Ramesh; Takeshi Yura; Saravanakumar Dhakshinamoorthy; Aimo Kannt
Journal:  Sci Rep       Date:  2022-09-14       Impact factor: 4.996

4.  Jia-ga-song-tang protection against alcoholic liver and intestinal damage.

Authors:  Jiamin Fang; Yuhuan Wu; Changlian Gan; Shufang Ruan; Xiaoliang He; Bixia Wang; Ying Wang; Jingtao Yu; Chuanlan Sang; Dawa Zeren; Tianqin Xiong
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.